Literature DB >> 11087019

Cognitive impairment and enduring negative symptoms: a comparative study of geriatric and nongeriatric schizophrenia patients.

K M Putnam1, P D Harvey.   

Abstract

Chronically institutionalized geriatric (n = 174; average length of hospitalization = 35.1 years) and nongeriatric (n = 59; average length of hospitalization = 17.3 years) schizophrenia patients were classified with regard to their enduring negative symptoms (ENS) over a year. All patients completed neuropsychological tests that have been previously found to be implicated in geriatric schizophrenia: the Mini-Mental State Examination (MMSE), the Modified Boston Naming Test, Constructional Praxis, and Word List Learning and Delayed Recall. With MMSE scores used as covariates, ENS status and age group effects were examined on the cognitive measures at the second assessment. Results indicated that there was considerable specificity of cognitive impairment in the ENS syndrome even in patients with a chronic course of unremitting illness. Furthermore, when specific cognitive measures were examined and global impairment statistically controlled for, patients with ENS manifested a distinct pattern of impairment, rather than uniformly inferior performance. In particular, patients with ENS performed more poorly on tests putatively sensitive to frontal and parietal lobe functions, replicating earlier results on younger patients with a much better overall functional outcome. These data suggest that ENS defines a distinct subgroup of patients that can be identified even against the backdrop of chronic institutionalization.

Entities:  

Mesh:

Year:  2000        PMID: 11087019     DOI: 10.1093/oxfordjournals.schbul.a033501

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  9 in total

Review 1.  Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date.

Authors:  Alex S Cohen; Alice M Saperstein; James M Gold; Brian Kirkpatrick; William T Carpenter; Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-12-11       Impact factor: 9.306

2.  From Memories of Past Experiences to Present Motivation? A Meta-analysis on the Association Between Episodic Memory and Negative Symptoms in People With Psychosis.

Authors:  Matthias Pillny; Katarina Krkovic; Laura Buck; Tania M Lincoln
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 7.348

3.  Right-hemisphere encephalopathy in elderly subjects with schizophrenia: evidence from neuropsychological and brain imaging studies.

Authors:  V S Gabrovska-Johnson; M Scott; S Jeffries; N Thacker; R C Baldwin; A Burns; S W Lewis; J F W Deakin
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

4.  Olfactory hedonic judgment in patients with deficit syndrome schizophrenia.

Authors:  Gregory P Strauss; Daniel N Allen; Sylvia A Ross; Lisa A Duke; Jason Schwartz
Journal:  Schizophr Bull       Date:  2009-02-17       Impact factor: 9.306

5.  Deficit schizophrenia: an update.

Authors:  Brian Kirkpatrick; Silvana Galderisi
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

Review 6.  Should cognitive deficit be a diagnostic criterion for schizophrenia?

Authors:  Ralph Lewis
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186

7.  Neurocognitive impairment in the deficit subtype of schizophrenia.

Authors:  Gagan Fervaha; Ofer Agid; George Foussias; Ishraq Siddiqui; Hiroyoshi Takeuchi; Gary Remington
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-11       Impact factor: 5.270

8.  Decreased default mode neural modulation with age in schizophrenia.

Authors:  Christopher C Abbott; Dae Kim; Scott R Sponheim; Juan Bustillo; Vince D Calhoun
Journal:  Am J Geriatr Psychiatry       Date:  2010-10       Impact factor: 4.105

9.  Course of neurological soft signs in first-episode schizophrenia: Relationship with negative symptoms and cognitive performances.

Authors:  Raymond C K Chan; Fu-Lei Geng; Simon S Y Lui; Ya Wang; Karen K Y Ho; Karen S Y Hung; Raquel E Gur; Ruben C Gur; Eric F C Cheung
Journal:  Sci Rep       Date:  2015-06-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.